[1] |
GONZÁLEZ-NAVAJAS J M, LEE J, DAVID M, et al. Immunomodulatory functions of type I interferons[J]. Nat Rev Immunol, 2012, 12(2):125-135.
|
[2] |
MALMGAARD L. Induction and regulation of IFNs during viral infections[J]. J Interferon Cytokine Res, 2004, 24(8):439-454.
|
[3] |
ZHAO N, YAO H P, LAN L P, et al. Efficient production of canine interferon-alpha in silkworm Bombyx mori by use of a BmNPV/Bac-to-Bac expression system[J]. Appl Microbiol Biotechnol, 2008, 78(2):221-226.
|
[4] |
SIEGAL P F, KADOWAKI N, SHODELL M, et al. The nature of the principal type 1 interferon-producing cells in human blood[J]. Science, 1999, 284(5421):1835-1837.
|
[5] |
高琳,汪崇,杨文亮. 中药疗法和干扰素对犬瘟热治疗效果的比较研究[J]. 现代畜牧兽医, 2012(5):44-47.
|
|
GAO L, WANG C, YANG W L. Comparative study on the therapeutic effect of traditional Chinese medicine therapy and interferon on canine distemper[J]. Modern Journal of Animal Husbandry and Veterinary Medicine, 2012(5):44-47. (in Chinese)
|
[6] |
张考,靳慧君,仲飞,等. 腺病毒介导犬干扰素-γ基因的表达及其体外抗犬细小病毒的作用[J]. 微生物学报, 2012, 52(11):1400-1407.
|
|
ZHANG K, JIN H J, ZHONG F, et al. Adenovirus-mediated canine interferon-γ expression and its antiviral activity against canine parvovirus[J]. Acta Microbiologica Sinica, 2012, 52(11):1400-1407. (in Chinese)
|
[7] |
ITO A, ISOGAI E, YOSHIOKA K, et al. Ability of orally administered IFN-α4 to inhibit naturally occurring gingival inflammation in dogs[J]. J Vet Med Sci, 2010, 72(9):1145-1151.
|
[8] |
CHAI H, VAN VASUDE S G, PORTER A G, et al. Glycosylation and high-level secretion of human tumour necrosis factor-beta in recombinant baculovirus-infected insect cells[J]. Biotechnol Appl Biochem, 1993, 18(3):259-273.
|
[9] |
DRUGMAND J C, SCHNEIDER Y J, AGATHOS S N. Insect cells as factories for biomanufacturing[J]. Biotechnol Adv, 2012, 30(5):1140-1157.
|
[10] |
DAI X J, HAJÍS J P, JOOSTEN N N, et al. Isolation of a Spodoptera exigua baculovirus recombinant with a 10.6 kbp genome deletion that retains biological activity[J]. J Gen Virol, 2000, 81(10):2545-2554.
|
[11] |
AILOR E, BETENBAUGH M J. Modifying secretion and post-translational processing in insect cells[J]. Curr Opin Biotechnol, 1999, 10(2):142-145.
|
[12] |
RUTTANAPUMMA R, ANZAI M, TAKEGAWA M, et al. High level expression of biologically active canine interferon-α subtype 4 using a baculovirus[J]. J Vet Med Sci, 2006, 68(12):1347-1349.
|
[13] |
VEZALI E, AGHEMO A, COLOMBO M. Interferon in the treatment of chronic hepatitis C:a drug caught between past and future[J]. Expert Opin Biol Ther, 2011, 11(3):301-310.
|
[14] |
KWON H, LOK A S. Hepatitis B therapy[J]. Nat Rev Gastroenterol Hepatol, 2011, 8(5):275-284.
|
[15] |
SUBRAMANIAN G M, FISCELLA M, LAMOUSÉ-SMITH A, et al. Albinterferon α-2b:a genetic fusion protein for the treatment of chronic hepatitis C[J]. Nat Biotechnol, 2007, 25(12):1411-1419.
|
[16] |
ZHAO H L, XUE C, WANG Y, et al. Circumventing the heterogeneity and instability of human serum albumin-interferon-α2b fusion protein by altering its orientation[J]. J Biotechnol, 2007, 131(3):245-252.
|
[17] |
ZHAO H L, YAO X Q, XUE C, et al. Increasing the homogeneity, stability and activity of human serum albumin and interferon-α2b fusion protein by linker engineering[J]. Protein Expr Purif, 2008, 61(1):73-77.
|
[18] |
KLEMENT M, LIU C C, LOO B L W, et al. Effect of linker flexibility and length on the functionality of a cytotoxic engineered antibody fragment[J]. J Biotechnol, 2015, 199:90-97.
|
[19] |
TAIRA O, WATANUGI I, HAGIWARA Y, et al. Cloning and expression of canine interferon-α genes in Escherichia coli[J]. J Vet Med Sci, 2005, 67(10):1059-1062.
|
[20] |
徐晓娟, 王怡飞,王玉,等. 犬干扰素α1基因在大肠埃希菌中的表达及其抗病毒活性的测定[J]. 中国生物制品学杂志, 2013, 26(8):1084-1087, 1093.
|
|
XU X J, WANG Y F, WANG Y, et al. Expression of canine interferon α1 gene in E. coli and antiviral activity of expressed product[J]. Chinese Journal of Biologicals, 2013, 26(8):1084-1087, 1093. (in Chinese)
|
[21] |
潘福星, 朱梅胜,冯培祥,等. 比格犬α7干扰素成熟肽基因的原核表达及表达产物活性的分析[J]. 中国兽医科学, 2014, 44(3):298-302.
|
|
PAN F X, ZHU M S, FENG P X, et al. Prokaryotic expression of Beagle IFN-α7 gene and analysis of its antiviral activities[J]. Chinese Veterinary Science, 2014, 44(3):298-302. (in Chinese)
|
[22] |
姚凌云, 王晶宇,欧阳伟,等. 犬干扰素α2的原核表达及抗病毒活性分析[J]. 中国动物传染病学报, 2018, 26(2):59-63.
|
|
YAO L Y, WANG J Y, OUYANG W, et al. Prokaryotic expression and antiviral analysis of canine interferon α2[J]. Chinese Journal of Animal Infectious Diseases, 2018, 26(2):59-63. (in Chinese)
|
[23] |
SISK W P, BRADLEY J D, LEIPOLD R J, et al. High-level expression and purification of secreted forms of herpes simplex virus type 1 glycoprotein gD synthesized by baculovirus-infected insect cells[J]. J Virol, 1994, 68(2):766-775.
|
[24] |
杜明梅, 叶玲,刘建伟,等. Kozak序列+4G提高绿色荧光蛋白在HEK293细胞中的表达[J]. 生物工程学报, 2008, 24(3):491-494.
|
|
DU M M, YE L, LIU J W, et al. Enhancement of GFP expression by Kozak sequence +4G in HEK293 cells[J]. Chinese Journal of Biotechnology, 2008, 24(3):491-494. (in Chinese)
|
[25] |
HUANG Y S, CHEN Z, YANG Z Y, et al. Preparation and characterization of a potent, long-lasting recombinant human serum albumin-interferon-α2b fusion protein expressed in Pichia pastoris[J]. Eur J Pharm Biopharm, 2007, 67(2):301-308.
|
[26] |
OSBORN B L, OLSEN H S, NARDELLI B, et al. Pharmacokinetic and pharmacodynamic studies of a human serum albumin-interferon-α fusion protein in cynomolgus monkeys[J]. J Pharmacol Exp Ther, 2002, 303(2):540-548.
|
[27] |
王晶宇, 欧阳伟,王永山,等. 犬干扰素α4在CHO细胞中的稳定表达[J]. 中国兽医科学, 2017, 47(4):448-454.
|
|
WANG J Y, OUYANG W, WANG Y S, et al. Stable expression of canine interferon α4 in CHO cell[J]. Chinese Veterinary Science, 2017, 47(4):448-454. (in Chinese)
|